Inhibition of gelatinase B (matrix metalloproteinase-9) by dihydrolipoic acid

Canadian Journal of Physiology and Pharmacology

Volumn 83, Issue 3, 2005, Pages 301-308

  Cantin, André M ^a   Martel, Marc ^a   Drouin, Geneviève ^a   Paquette, Benoit ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Inflammation; Matrix metalloproteinases; Neutrophils; Pulmonary fibrosis; Thiols

Indexed keywords

BUFFER; DIHYDROLIPOATE; DISULFIDE; DITHIOL DERIVATIVE; ENZYME PRECURSOR; FATTY ACID; GELATINASE B; THIOCTIC ACID; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET; DIETARY INTAKE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; EXTRACELLULAR SPACE; FATTY ACID OXIDATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPOTHESIS; IC 50; INCUBATION TIME; LUNG FIBROSIS; LUNG LAVAGE; MAMMAL CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME INHIBITORS; ENZYME PRECURSORS; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; NEUTROPHILS; PULMONARY FIBROSIS; THIOCTIC ACID;

EID: 21744435264     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-019     Document Type: Article

References (36)

1. Atkinson, J.J., and Senior, R.M. 2003. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell Mol. Biol. 28: 12-24.
2. Beekman, B., Drijfhout, J.W., Bloemhoff, W., Ronday, H.K., Tak, P.P., and te Koppele, J.M. 1996. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Lett. 390: 221-225.
3. Bernardo, M.M., Brown, S., Li, Z.H., Fridman, R., and Mobashery, S. 2002. Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases. J. Biol. Chem. 277: 11201-11207.
4. Berton, A., Godeau, G., Emonard, H., Baba, K., Bellon, P., Hornebeck, W. et al. 2000. Analysis of the ex vivo specificity of human gelatinases A and B towards skin collagen and elastic fibers by computerized morphometry. Matrix Biol. 19: 139-148.
5. Berton, A., Rigot, V., Huet, E., Decarme, M., Eeckhout, Y., Patthy, L. et al. 2001. Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids. J. Biol. Chem. 276: 20458-20465.
6. Betsuyaku, T., Fukuda, Y., Parks, W.C., Shipley, J.M., and Senior, R.M. 2000. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am. J. Pathol. 157: 525-535.
7. Biewenga, G.P., Haenen, G.R., and Bast, A. 1997. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29: 315-331.
8. Cantin, A. M., Larivee, P., Martel, M., and Begin, R. 1992. Hyaluronan (hyaluronic acid) in lung lavage of asbestos-exposed humans and sheep. Lung, 170: 211-220.
9. Chuang, D.T. 1989. Molecular studies of mammalian branched-chain alpha-keto acid dehydrogenase complexes: domain structures, expression, and inborn errors. Ann. N. Y. Acad. Sci. 573: 137-154.
10. Creemers, E.E., Cleutjens, J.P., Smits, J.F., and Daemen, M.J. 2001. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ. Res. 89: 201-210.
11. Ellman, G.L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82: 70-77.
12. Flaherty, K.R., Toews, G.B., Lynch, J.P., 3rd, Kazerooni, E.A., Gross, B.H., Strawderman, R.L. et al. 2001. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am. J. Med. 110: 278-282.
13. Flaherty, K.R., Toews, G.B., Travis, W.D., Colby, T.V., Kazerooni, E.A., Gross, B.H. et al. 2002. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur. Respir. J. 19: 275-283.
14. Flaherty, K.R., Thwaite, E.L., Kazerooni, E.A., Gross, B.H., Toews, G.B., Colby, T.V. et al. 2003. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 58: 143-148.
15. Handelman, G.J., Han, D., Tritschler, H., and Packer, L. 1994. Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium. Biochem. Pharmacol. 47: 1725-1730.
16. Honda, T., Ota, H., Arai, K., Hayama, M., Fujimoto, K., Yamazaki, Y., and Haniuda, M. 2002. Three-dimensional analysis of alveolar structure in usual interstitial pneumonia. Virchows Arch. 441: 47-52.
17. John, A., and Tuszynski, G. 2001. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 7: 14-23.
18. Kaito, K., Urayama, H., and Watanabe, G. 2003. Doxycycline treatment in a model of early abdominal aortic aneurysm. Surg. Today, 33: 426-433.
19. Li de la Sierra, I., Pernot, L., Prange, T., Saludjian, P., Schiltz, M., Fourme, R. et al. 1997. Molecular structure of the lipoamide dehydrogenase domain of a surface antigen from Neisseria meningitidis. J. Mol. Biol. 269: 129-141.
20. Liu, Z., Zhou, X., Shapiro, S. D., Shipley, J. M., Twining, S. S., Diaz, L. A. et al. 2000. The serpin alpha 1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell, 102: 647-655.
21. Longo, G.M., Xiong, W., Greiner, T.C., Zhao, Y., Fiotti, N., and Baxter, B.T. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110: 625-632.
22. Marracci, G.H., Jones, R.E., McKeon, G.P., and Bourdette, D.N. 2002. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J. Neuroimmunol. 131: 104-114.
23. Massova, I., Kotra, L.P., Fridman, R., and Mobashery, S. 1998. Matrix metalloproteinases: structures, evolution, and diversification. Faseb J. 12: 1075-1095.
24. Melhem, M.F., Craven, P.A., Liachenko, J., and DeRubertis, RR. 2002. Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J. Am. Soc. Nephrol. 13: 108-116.
25. Nagase, H. 1997. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378: 151-160.
26. Nagase, H., and Woessner, J.F., Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274: 21491-21494.
27. Packer, L., Witt, E.H., and Tritschler, H.J. 1995. alpha-Lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19: 227-250.
28. Packman, L.C., Hale, G., and Perham, R.N. 1984. Repeating functional domains in the pyruvate dehydrogenase multienzyme complex of Escherichia coli. Embo J. 3: 1315-1319.
29. Paquette, B., Bisson, M., Therriault, H., Lemay, R., Pare, M., Banville, P., and Cantin, A. M. 2003. Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol. J. Steroid Biochem. Mol. Biol. 87: 65-73.
30. Rajagopalan, S., Meng, X.P., Ramasamy, S., Harrison, D.G., and Galis, Z.S. 1996. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98: 2572-2579.
31. Rennard, S.I., Basset, G., Lecossier, D., O'Donnell, K.M., Pinkston, P., Martin, P.G., and Crystal, R.G. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60: 532-538.
32. Sinha, S., and Frishman, W.H. 1998. Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target. J. Clin. Pharmacol. 38: 1077-1088.
33. Suga, M., Iyonaga, K., Okamoto, T., Gushima, Y., Miyakawa, H., Akaike, T., and Ando, M. 2000. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 162: 1949-1956.
34. Thompson, R.W., and Parks, W.C. 1996. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann. N. Y. Acad. Sci. 800: 157-174.
35. Wilhelm, S.M., Collier, I.E., Manner, B.L., Eisen, A.Z., Grant, G.A., and Goldberg, G.I. 1989. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264: 17213-17221.
36. Zaoui, P., Cantin, J.F., Alimardani-Bessette, M., Monier, F., Halimi, S., Morel, F., and Cordonnier, D. 2000. Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions. Diabetes Metab. 26 Suppl 4: 25-29.